Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

DRUG POLICY ALLIANCE

Filed by DRUG POLICY ALLIANCE.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 19, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
39963ff1-beba-4a6c-8620-789e5542bcba
Termination date
Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

LAW · Law Enforcement/Crime/Criminal Justice

We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).

Literal federal measure citations: H.R. 5068, H.R. 1266, S. 545, H.R. 5415, S. 3076, H.R. 7970

CIV · Civil Rights/Civil Liberties

We urged Congress to support the RESTORE Act (H.R. 5223), a bill that would end the SNAP drug felony ban. We urged Congress to repeal the Thurmond Amendment to end housing discrimination via a bill called the Fair Future Act (H.R. 7765).

Literal federal measure citations: H.R. 5223, H.R. 7765

HCR · Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills. We opposed the inclusion of a rider to ban overdose prevention centers in Congressional spending bills.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.